AAAAAA

   
Results: 1-5 |
Results: 5
The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects
Authors: Zdravkovic, M Christiansen, T Eliot, L Agersoe, H Thomsen, MS Falch, JF Sogaard, B Ynddal, L Ilondo, MM
Citation: M. Zdravkovic et al., The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects, GROWTH H I, 11(1), 2001, pp. 41-48
Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society (Reprinted from J Clin Endocrinol Metab, vol 85, pg 3990-3993,2000)
Authors: Attie, KM Bengtsson, BA Blethen, SL Blum, W Cameron, F Carel, JC Carlsson, L Chipman, JJ Christiansen, JS Clayton, P Clemmons, DR Cohen, P Drop, S Fujieda, K Ghigo, E Hintz, RL Ho, K Ilondo, MM Jasper, H Jesussek, B Kappelgaard, AM Laron, Z Lippe, BM Malozowski, S Mullis, PE de Muinck-Keizer-Schrama, S Nishi, Y Parks, JS Phelps, C Ranke, M Robinson, I Rosenfeld, RG Rose, S Saenger, P Saggese, G Savage, M Shalet, S Sizonenko, PC Strasburger, C Tachibana, K Tanaka, T Thorner, MO Wikland, KA Zadik, Z
Citation: Km. Attie et al., Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society (Reprinted from J Clin Endocrinol Metab, vol 85, pg 3990-3993,2000), J PED END M, 14(4), 2001, pp. 377-382
Evaluation of the conformity of human growth hormone concentrations measured with the DPC Immulite (R) and the Nichols (R) Advantage (TM) assays
Authors: Zdravkovic, M Christiansen, T Grosch, K Ilondo, MM
Citation: M. Zdravkovic et al., Evaluation of the conformity of human growth hormone concentrations measured with the DPC Immulite (R) and the Nichols (R) Advantage (TM) assays, CLIN CH L M, 38(8), 2000, pp. 799-800
The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers
Authors: Zdravkovic, M Sogaard, B Ynddal, L Christiansen, T Agerso, H Thomsen, MS Falch, JE Ilondo, MM
Citation: M. Zdravkovic et al., The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers, GROWTH H I, 10(4), 2000, pp. 193-198
Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society
Authors: Israel, E Attie, KM Bengtsson, BA Blethen, SL Blum, W Cameron, F Carel, JC Carlsson, L Chipman, JJ Christiansen, JS Clayton, P Clemmons, DR Cohen, P Drop, S Fujieda, K Ghigo, E Hintz, RL Ho, K Ilondo, MM Jasper, H Jesussek, B Kappelgaard, AM Laron, Z Lippe, BM Malozowski, S Mullis, PE de Munick-Keizer-Schrama, S Nishi, Y Parks, JS Phelps, C Ranke, M Robinson, I Rosenfeld, RG Rose, S Saenger, P Saggese, G Savage, M Shalet, S Sizonenko, PC Strasburger, C Tachibana, K Tanaka, T Thorner, MO Wikland, KA Zadik, Z
Citation: E. Israel et al., Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society, J CLIN END, 85(11), 2000, pp. 3990-3993
Risultati: 1-5 |